A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Conditions
Duchene Muscular Dystrophy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arkansas Children's Research Institute, Little Rock, Arkansas, United States
Contact: Principal Investigator (Aravindhan Veerapandiyan)Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Sarah Wright, DO)Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Bridget McGowan)Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Gerald Mastellone) · Gerald.mastellone@childrens.harvard.edu · 857-218-4677Contact: Principal Investigator (Partha Ghosh, MD)University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
Contact: Principal Investigator (Stephen Chrzanowski)Columbia University Medical Center, New York, New York, United States
Contact: Principal Investigator (Divya Jayaraman)Duke University / Lenox Baker Children's Hospital, Durham, North Carolina, United States
Contact: Principal Investigator (Natalie Katz, MD)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Erika Finanger, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Macarena Racciatti) · macarena.racciatti@seattlechildrens.org · 206-995-6847Contact: Principal Investigator (Alicia Henriquez)